| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.41B | 22.10B | 18.56B | 11.78B | 11.95B | 12.19B |
| Gross Profit | 13.45B | 11.00B | 6.42B | 1.17B | 2.14B | 2.38B |
| EBITDA | 16.88B | 14.83B | 7.87B | 1.86B | 3.28B | 5.54B |
| Net Income | 8.46B | 7.08B | 3.35B | -2.52B | -459.00M | 1.17B |
Balance Sheet | ||||||
| Total Assets | 57.67B | 57.12B | 56.35B | 55.51B | 38.48B | 40.56B |
| Cash, Cash Equivalents and Short-Term Investments | 8.78B | 8.24B | 3.64B | 3.02B | 3.76B | 5.07B |
| Total Debt | 5.53B | 5.71B | 8.97B | 9.44B | 6.13B | 6.30B |
| Total Liabilities | 22.57B | 23.08B | 26.24B | 26.30B | 18.95B | 18.70B |
| Stockholders Equity | 34.93B | 33.87B | 29.93B | 29.03B | 19.35B | 22.02B |
Cash Flow | ||||||
| Free Cash Flow | 12.27B | 7.30B | 2.96B | 97.00M | 1.09B | 2.63B |
| Operating Cash Flow | 12.09B | 10.33B | 6.36B | 2.76B | 3.22B | 4.28B |
| Investing Cash Flow | -434.00M | 739.00M | -2.70B | -1.00B | -2.98B | -1.87B |
| Financing Cash Flow | -7.74B | -7.17B | -2.95B | -1.60B | -2.36B | -2.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | $107.00B | 12.86 | 25.22% | 0.95% | 25.14% | 73.19% | |
76 Outperform | $32.38B | 8.75 | 50.82% | 1.51% | 68.87% | 187.55% | |
76 Outperform | $10.26B | 37.44 | 11.04% | 0.07% | 56.81% | 525.85% | |
73 Outperform | $9.95B | 9.86 | 32.51% | 0.87% | 31.10% | 57.19% | |
73 Outperform | $17.62B | 27.74 | 11.91% | 0.77% | 70.98% | 38.91% | |
70 Outperform | $43.58B | 12.54 | 43.79% | 2.82% | ― | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |